Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference

To respond to the legitimate questions raised by the application of invasive methods of monitoring and life-support techniques in cancer patients admitted in the ICU, the European Lung Cancer Working Party and the Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique, set up a consensus conference. The methodology involved a systematic literature review, experts’ opinion and a final consensus conference about nine predefined questions 1. Which triage criteria, in terms of complications and considering the underlying neoplastic disease and possible therapeutic limitations, should be used to guide admission of cancer patient to intensive care units? 2. Which ventilatory support [High Flow Oxygenation, Non-invasive Ventilation (NIV), Invasive Mechanical Ventilation (IMV), Extra-Corporeal Membrane Oxygenation (ECMO)] should be used, for which complications and in which environment? 3. Which support should be used for extra-renal purification, in which conditions and environment? 4. Which haemodynamic support should be used, for which complications, and in which environment? 5. Which benefit of cardiopulmonary resuscitation in cancer patients and for which complications? 6. Which intensive monitoring in the context of oncologic treatment (surgery, anti-cancer treatment …)? 7. What specific considerations should be taken into account in the intensive care unit? 8. Based on which criteria, in terms of benefit and complications and taking into account the neoplastic disease, patients hospitalized in an intensive care unit (or equivalent) should receive cellular elements derived from the blood (red blood cells, white blood cells and platelets)? 9. Which training is required for critical care doctors in charge of cancer patients? SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00134-021-06508-w.